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Introduction: The International Depression and Anxiety Epidemiological Study (TIDES) in CF attempts to provide prevalence data for mental
distress in CF patients. The current study reports the results from the UK pilot in a single major CF centre in which the performances of different
instruments were compared, and risk of self harm measured.
Methods: Two mental health assessment screening instruments, the Hospital Anxiety and Depression Scale (HADS) and the Patient Health
Questionnaire for depression (PHQ-9) were given to all adults with CF attending the Regional Adult CF Unit in Leeds, UK.
Results: 232 patients took part. 13 (5.6%) scored in the clinical range for depression on the HADS and 78 (33.4%) on the PHQ9. The suicide risk
item on the PHQ9 was endorsed by 24 patients (10.4%).
Discussion: Major discrepancies were found in rates of depression detected by two popular screening tools. A signiﬁcant minority of respondents
indicated suicidal ideation. Work is needed to identify the most appropriate screening tool for depression in this population, and it is important that
this includes an assessment of self harm.
© 2013 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cystic ﬁbrosis; Depression; Suicide; Screening1. Introduction
There is a complex and important relationship between
mental health and physical illness. Chronic illness is associated
with increased rates of depression (e.g. double the general
population prevalence in diabetes [1]) and increased suicide
risk [2]. In turn, mental health is known to affect outcome in
physical illness both in ways which are not well understood,
such as the relationship between depression and survival after a
heart attack [3], and ways which are more direct, such as
adherence to medication [4].
In CF, prevalence of mental health problems remains
relatively unexplored though there are indications that anxiety
and depression both appear to be more prevalent in CF than the
general population [5]. The International Depression and
Anxiety Epidemiological Study (TIDES) in CF is an attempt⁎ Corresponding author at: Leeds Institute of Health Sciences, University of
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different countries. This study reports on the results from the
TIDES UK pilot in a single major adult CF centre, where the
primary TIDES measure was supplemented with an additional
measure of depression which included an item assessing risk of
suicide.2. Methods
Adults with CF attending the Regional Adult CF Unit in
Leeds, UK, were asked to complete a demographic question-
naire and two mental health screening instruments before
routine out-patient appointments: the Hospital Anxiety and
Depression Scale (HADS) [6] is a 14-item self-report measure
designed for use with hospital out-patients and selected for use
in the TIDES study. Participants indicate severity of symptoms
of anxiety and depression over the past week on a 4-point scale.
Somatic symptoms are not included in the HADS to avoid
overlap with symptoms of physical illness. The Patient Healthby Elsevier B.V. All rights reserved.
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inventory derived from the PRIME-MD clinical interview. It
has nine items which correspond with the nine diagnostic
criteria for major depressive disorder detailed in the Diagnostic
and Statistical Manual of Mental Disorders (DSM–IV). Patients
are asked to indicate the frequency that each symptom has been
experienced over the past two weeks on a scale of 0–3. It
includes one item which assesses suicidal ideation. Although
initially developed as a diagnostic instrument rather than a
screening tool, it has been recommended as a screening
instrument in primary care [8] where it has been shown to be
more suited to screening than diagnosis, performing less well at
measuring severity [9]. Both measures are popular and generally
considered to be useful in hospital settings [10].3. Results
232 patients participated (132 male; mean FEV1 61.8%, SD
22.6%). 84 and 43 participants were in full-time and part-time
employment respectively, 10 (4.5%) were engaged in psycho-
logical therapy and 5 (2.2%) were prescribed medication for
anxiety or depression.
HADS depression data showed 12 (5.2%) scored in the
borderline/mild and one in the moderate range (0.4%). In
contrast, PHQ-9 data showed 49 (21%) in the mild and 29
(12.4%) in the moderate-severe range. A matrix comparing the
results for both measures of depression is shown in Table 1.
10.4% (24 of 232; 95% CI, 7% to 15%) endorsed the item
on suicidal ideation on the PHQ-9. Three participants indicated
that they had experienced suicidal ideation ‘nearly every day’.
One participant was deemed to be at ‘immediate risk’ of a
suicide attempt and engaged in immediate intervention.4. Discussion
This study found that HADS depression scores were
relatively low, with 12 (5.2%) scoring in the mild and one
(0.4%) in the moderate range. In contrast, PHQ-9 data indicated
that over a third of participants (n = 78, 33.4%), had at least
mild depression. Of these only 11 were also identified by the
HADS. Using a stricter cut-off on the PHQ-9 (moderate
depression and above), only partially reduces this discrepancy,
with the HADS still only identifying 7 of the 29 participants
identified as depressed on the PHQ-9.Table 1
Depression severity ratings on HADS-D & PHQ-9.
PHQ depression category
None Mild Moderate Moderate/
severe
Severe Total
HADS
depression
category
None 153 45 16 4 1 219
Borderline 1 4 5 2 0 12
Moderate 0 0 0 1 0 1
Severe 0 0 0 0 0 0
Total 154 49 21 7 1 232In considering what might account for this discrepancy, the
HADS and PHQ-9 differ in a number of ways. First, the time
frame for reporting symptoms is different (one week for the
HADS, two for PHQ-9). More significantly, the items also
differ: the HADS was designed to avoid a confound between
somatic symptoms of depression and symptoms of physical
illness and therefore focuses selectively on anhedonia and loss
of interest. The PHQ-9 might therefore have misclassified
symptoms of CF as symptoms of depression; however a similar
sized discrepancy between the two measures has previously
been noted in primary care patients who were unlikely to have
presented with such severe somatic symptoms of ill-health [10].
Alternatively, as the PHQ-9 was originally a diagnostic tool and
the items mirror the diagnostic criteria of the main psychiatric
classification systems, it may be argued that it is a more accurate
measure of depression. However, although the PHQ-9 has been
found to correspond to diagnosis by a psychiatrist using a
structured interview [11], doubts have been raised about the
accuracy of the PHQ-9 in estimating severity [9].
The implication is that care must be taken in choosing
screening instruments for use in CF in terms of the balance
between potential false-positives and false-negatives and research
is needed to determine age and gender appropriate cut-offs for this
population. Dissemination from TIDES will include recommen-
dations on appropriate measures of depression and anxiety for
CF groups, and how these can be incorporated into annual
assessment.
Finally, the PHQ-9 includes an item on suicidal ideation. This
was endorsed by 24 participants (10.4%), a higher proportion than
previously reported in primary care [12] and cancer patients [13].
Higher ratings on this item were associated with higher scores on
other symptoms of depression, as found in previous research using
the PHQ-9 [14]. Although the item on the PHQ-9 does not
distinguish between passive (thoughts about being better off
dead), and active (hurting yourself) ideation, this figure suggests
that this area warrants serious further attention. Interpretation is
not straightforward, however. Not all those scoring on this item
will be at risk, though even a score of 1 has previously been found
to indicate suicidal intent in some patients, and higher scores
generally indicate a greater likelihood of suicidal intent [15].
Equally, not all suicidal patients score high on this item— though
it has been found to have a sensitivity of 0.69 for detecting
suicidality, the false-negative rate is approximately 11% [16]. The
PHQ-9 is potentially useful in detecting suicidality but no
screening tool is a substitute for a clinical interview and CF
teams need to be conscious of where to refer for risk assessment if
there is no integrated psychosocial professional within the Team.
In summary, whilst it remains important to identify depression
accurately in CF patients, this study highlights discrepancies
between measures in detecting depression in adults with CF.
Ultimately, regardless of the instrument employed, a high score
should routinely be followed up with a clinical interview and
further assessment, with referral for psychological intervention
only when necessary and with the patient's consent. This study
provides strong evidence that care is needed when choosing a
screening instrument for depression and even more so when
interpreting the results.
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